Aurora Cannabis Operating Income Over Time
| ACB Stock | USD 3.48 0.17 5.14% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Aurora Cannabis Performance and Aurora Cannabis Correlation. Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aurora Cannabis. If investors know Aurora will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Aurora Cannabis assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.95) | Earnings Share (1.09) | Revenue Per Share | Quarterly Revenue Growth 0.068 | Return On Assets |
Understanding Aurora Cannabis requires distinguishing between market price and book value, where the latter reflects Aurora's accounting equity. The concept of intrinsic value - what Aurora Cannabis' is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Aurora Cannabis' price substantially above or below its fundamental value.
Understanding that Aurora Cannabis' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Aurora Cannabis represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Aurora Cannabis' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Income Analysis
Compare Aurora Cannabis and related stocks such as Alpha Teknova, Canopy Growth Corp, and Lifecore Biomedical Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TKNO | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | 4.7 M | (12 M) | (49.7 M) | (35.6 M) | (26.1 M) | (23.5 M) | (24.7 M) |
| CGC | (26.9 K) | (21.4 K) | (64.6 K) | (931.7 K) | (6.7 M) | (2.7 M) | (15.2 M) | (78.9 M) | (553.6 M) | (1.7 B) | (1.2 B) | (1 B) | (2.6 B) | (228.7 M) | (117.1 M) | (6.7 M) | (7.1 M) |
| LFCR | (5.6 M) | 14.6 M | 24.9 M | 20.2 M | 18.5 M | (19.8 M) | 15.5 M | 11.8 M | (8 M) | (25.9 M) | (8.8 M) | (3.6 M) | (11.8 M) | (8.8 M) | (17.2 M) | (15.5 M) | (14.7 M) |
| BIOA | (41.2 M) | (41.2 M) | (41.2 M) | (41.2 M) | (35.2 M) | (38.5 M) | (29.6 M) | (110 M) | (40 M) | (40 M) | (40 M) | (40 M) | (40 M) | (48.4 M) | (78.2 M) | (70.4 M) | (73.9 M) |
| IRWD | (39.6 M) | (66.1 M) | (72.8 M) | (252 M) | (169.4 M) | (102.1 M) | (51.9 M) | (77.4 M) | (238.9 M) | 120.1 M | 142.9 M | 232.3 M | 250.3 M | (945.4 M) | 93.1 M | 83.8 M | 88 M |
| OGI | (140.2 K) | (140.2 K) | (375.2 K) | (1.6 M) | (1.2 M) | 1.2 M | (11.1 M) | 36.4 M | 5.5 M | (145.5 M) | (91.8 M) | (43.2 M) | (242.7 M) | (35.7 M) | (63.4 M) | (57.1 M) | (59.9 M) |
| HITI | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 1.6 M | 958.8 K | (3.7 M) | (19.6 M) | (677 K) | (18.7 M) | (72.3 M) | (41.4 M) | 5 M | (14.4 M) | (13 M) | (13.7 M) |
| LFMD | (576.4 K) | (576.4 K) | (540 K) | (546.4 K) | (530.9 K) | (262.2 K) | (1.2 M) | (1.1 M) | (2.1 M) | (2.9 M) | (57.8 M) | (54.3 M) | (43.4 M) | (14.5 M) | (16.1 M) | (14.5 M) | (15.3 M) |
| ACRS | (5.3 M) | (5.3 M) | (5.3 M) | (5.3 M) | (8.5 M) | (20.7 M) | (48.6 M) | (72.4 M) | (135.4 M) | (111.1 M) | (50.9 M) | (89.7 M) | (89.9 M) | (97.4 M) | (141.9 M) | (127.7 M) | (121.4 M) |
| EDIT | (5.2 M) | (5.2 M) | (5.2 M) | (5.2 M) | (12.7 M) | (35.3 M) | (97.2 M) | (119.9 M) | (113.7 M) | (140.9 M) | (134.8 M) | (193.1 M) | (225.9 M) | (169.2 M) | (251.2 M) | (226 M) | (214.7 M) |
Aurora Cannabis and related stocks such as Alpha Teknova, Canopy Growth Corp, and Lifecore Biomedical Operating Income description
Operating Income is the amount of profit realized from Aurora Cannabis operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Aurora Cannabis is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Aurora Cannabis | ACB |
| Classification | Cannabis |
| Business Address | 90B Street SW, |
| Exchange | NASDAQ Exchange |
USD 3.48
Check out Aurora Cannabis Performance and Aurora Cannabis Correlation. For information on how to trade Aurora Stock refer to our How to Trade Aurora Stock guide.You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Aurora Cannabis technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.